[Federal Register Volume 88, Number 121 (Monday, June 26, 2023)]
[Notices]
[Page 41419]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-13466]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1203]


Bulk Manufacturer of Controlled Substances Application: Arista 
Biologicals

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Arista Biologicals has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
SUPPLEMENTARY INFORMATION listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
August 25, 2023. Such persons may also file a written request for a 
hearing on the application on or before August 25, 2023.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on April 6, 2023, Arista Biologicals, 1101 Hamilton 
Street, Allentown, Pennsylvania 18101-1043, applied to be registered as 
a bulk manufacturer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
         Controlled substance            Drug code        Schedule
------------------------------------------------------------------------
4-Anilino-N-Phenethyl-4-Piperidine            8333  II
 (ANPP).
Norfentanyl (N-phenyl-N-(piperidin-4-         8366  II
 yl)propionamide).
------------------------------------------------------------------------

    The company plans to bulk manufacture the listed controlled 
substances for internal use as intermediates for formulation and 
analytical development purposes. No other activities for these drug 
codes are authorized for this registration.

Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-13466 Filed 6-23-23; 8:45 am]
BILLING CODE P